Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa |
| |
| Authors: | S. Wendt C. Whybra C. Kampmann E. Teichmann M. Beck |
| |
| Affiliation: | (1) Children’s University Hospital Mainz, Mainz;(2) Obstetrician, Northeim, Germany;(3) Children’s University Hospital Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany |
| |
| Abstract: | Summary Fabry disease is an inherited lysosomal storage disease caused by deficiency of α-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy. |
| |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
